These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7949498)

  • 21. [Differential therapeutic aspects of high blood pressure therapy with beta blockers].
    Bühler FR; Bolli P
    Schweiz Rundsch Med Prax; 1983 May; 72(20):684-90. PubMed ID: 6136031
    [No Abstract]   [Full Text] [Related]  

  • 22. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-blockers and depression in elderly hypertension patients in primary care.
    Ringoir L; Pedersen SS; Widdershoven JW; Pouwer F; Keyzer JM; Romeijnders AC; Pop VJ
    Fam Med; 2014 Jun; 46(6):447-53. PubMed ID: 24911300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating the role of incidental use of beta-blockers in patients with metastatic brain tumors in controlling tumor progression and survivability.
    Bir SC; Kalakoti P; Ahmed O; Bollam P; Nanda A
    Neurol India; 2015; 63(1):19-23. PubMed ID: 25751464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Withdrawal syndrome following beta blocker therapy (author's transl)].
    Hausen T
    MMW Munch Med Wochenschr; 1981 Oct; 123(42):1583-4. PubMed ID: 6796833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-receptor blocker withdrawal. A preoperative problem in general surgery?
    Pontén J; Biber B; Bjurö T; Henriksson BA; Hjalmarson A
    Acta Anaesthesiol Scand Suppl; 1982; 76():32-7. PubMed ID: 6152880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining other antihypertensive drugs with β-blockers in hypertension: a focus on safety and tolerability.
    Richards TR; Tobe SW
    Can J Cardiol; 2014 May; 30(5 Suppl):S42-6. PubMed ID: 24518661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-blocker withdrawal among patients presenting for surgery from home.
    Schonberger RB; Lukens CL; Turkoglu OD; Feinleib JL; Haspel KL; Burg MM
    J Cardiothorac Vasc Anesth; 2012 Dec; 26(6):1029-33. PubMed ID: 22418043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blocker withdrawal: the song of Orpheus.
    Eichhorn EJ
    Am Heart J; 1999 Sep; 138(3 Pt 1):387-9. PubMed ID: 10467182
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse effects of sudden withdrawal of antihypertensive medication.
    Hubbell FA; Weber MA
    Postgrad Med; 1980 Aug; 68(2):129-33, 136, 138. PubMed ID: 6105648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.